Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Susan H Alexander. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Susan H Alexander har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:BIIB / Biogen Inc. | EVP Chief Legal Officer | 36 265 |
US:IVC / Invacare Corp. | Director | 104 499 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Susan H Alexander. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Susan H Alexander som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-12 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −807 | 36 265 | −2,18 | 142,54 | −115 030 | 5 169 213 | |
2025-02-12 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 37 072 | 7,46 | ||||
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −591 | 34 497 | −1,68 | 141,35 | −83 538 | 4 876 151 | |
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 940 | 35 088 | 5,85 | ||||
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −643 | 33 148 | −1,90 | 141,35 | −90 888 | 4 685 470 | |
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 190 | 33 791 | 6,93 | ||||
2024-11-07 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | 20 082 | 20 082 | |||||
2024-11-07 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | −20 082 | 31 601 | −38,86 | ||||
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −781 | 51 683 | −1,49 | 219,08 | −171 101 | 11 322 712 | |
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 614 | 52 464 | 3,17 | ||||
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 656 | 50 850 | −3,15 | 219,08 | −362 796 | 11 140 218 | |
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 3 423 | 52 506 | 6,97 | ||||
2024-02-13 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −938 | 49 083 | −1,88 | 240,98 | −226 039 | 11 828 021 | |
2024-02-13 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 50 021 | 5,43 | ||||
2024-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −655 | 47 446 | −1,36 | 240,30 | −157 396 | 11 401 274 | |
2024-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 190 | 48 101 | 4,77 | ||||
2023-02-22 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −929 | 45 911 | −1,98 | 278,38 | −258 615 | 12 780 704 | |
2023-02-22 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 920 | 46 840 | 4,27 | ||||
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −2 737 | 44 920 | −5,74 | 286,30 | −783 603 | 12 860 596 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −701 | 47 657 | −1,45 | 286,30 | −200 696 | 13 644 199 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 448 | 48 358 | 3,09 | ||||
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −764 | 46 910 | −1,60 | 286,30 | −218 733 | 13 430 333 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 47 674 | 5,71 | ||||
2023-01-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 5 703 | 45 099 | 14,48 | ||||
2022-10-28 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −5 532 | 39 396 | −12,31 | 280,70 | −1 552 832 | 11 058 457 |
2022-04-05 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 39 474 | 104 499 | 60,71 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 137 | 7 248 | −22,77 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 485 | 9 385 | −13,66 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −659 | 44 928 | −1,45 | 209,79 | −138 252 | 9 425 445 | |
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 485 | 45 587 | 3,37 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 090 | 3 218 | −39,37 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 126 | 5 308 | −17,50 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 190 | 0 | −100,00 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 154 | 2 190 | −34,51 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 044 | 44 102 | −2,31 | 214,59 | −224 032 | 9 463 848 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −500 | 45 146 | −1,10 | 214,59 | −107 295 | 9 687 880 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 126 | 45 646 | 2,53 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −512 | 44 520 | −1,14 | 214,59 | −109 870 | 9 553 547 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 154 | 45 032 | 2,63 | ||||
2022-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 7 725 | 7 725 | |||||
2022-01-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 2 825 | 43 878 | 6,88 | ||||
2022-01-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | −523 | 41 053 | −1,26 | ||||
2021-03-16 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 13 388 | 65 025 | 25,93 | ||||
2021-02-22 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 870 | 10 870 | |||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 367 | 6 434 | −17,52 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 849 | 7 801 | −19,16 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 402 | 3 344 | −29,54 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 936 | 4 746 | −28,97 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 788 | 0 | −100,00 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 586 | 1 788 | −47,01 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −607 | 41 576 | −1,44 | 278,03 | −168 764 | 11 559 375 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −622 | 42 183 | −1,45 | 278,03 | −172 935 | 11 728 139 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −704 | 42 805 | −1,62 | 278,03 | −195 733 | 11 901 074 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 367 | 43 509 | 3,24 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 402 | 42 142 | 3,44 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 586 | 40 740 | 4,05 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 963 | 39 154 | −4,77 | 278,03 | −545 773 | 10 885 987 | |
2021-01-29 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 4 545 | 41 117 | 12,43 | ||||
2020-03-31 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 15 439 | 51 637 | 42,65 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 171 | 0 | −100,00 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 553 | 1 171 | −57,01 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −689 | 36 572 | −1,85 | 333,00 | −229 437 | 12 178 476 | |
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 553 | 37 261 | 4,35 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 803 | 6 682 | −21,25 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 535 | 8 485 | −15,32 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 697 | 0 | −100,00 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 633 | 3 374 | −32,61 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 735 | 5 007 | −25,73 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 9 650 | 9 650 | |||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −681 | 35 708 | −1,87 | 331,76 | −225 929 | 11 846 486 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 535 | 36 389 | 4,40 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −798 | 34 854 | −2,24 | 331,76 | −264 744 | 11 563 163 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 697 | 35 652 | 8,18 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −756 | 32 955 | −2,24 | 331,76 | −250 811 | 10 933 151 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 735 | 33 711 | 5,43 | ||||
2019-03-19 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 18 045 | 36 198 | 99,41 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Stock Option (Right to Buy) |
M - Exercise | −6 395 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −819 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 663 | 819 | −67,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −739 | 31 976 | −2,26 | 325,33 | −240 419 | 10 402 752 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −3 370 | 32 715 | −9,34 | 325,33 | −1 096 362 | 10 643 171 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 6 395 | 36 085 | 21,54 | 48,52 | 310 285 | 1 750 844 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 663 | 29 690 | 5,93 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 033 | 2 724 | −27,50 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 685 | 3 757 | −30,96 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −749 | 28 027 | −2,60 | 332,87 | −249 320 | 9 329 347 | |
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 685 | 28 776 | 6,22 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 020 | 10 020 | |||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 448 | 6 742 | −17,68 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 920 | 8 190 | −18,99 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 348 | 2 697 | −33,33 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −619 | 27 091 | −2,23 | 319,43 | −197 727 | 8 653 678 | |
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 920 | 27 710 | 7,44 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −402 | 25 790 | −1,53 | 319,43 | −128 411 | 8 238 100 | |
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 348 | 26 192 | 5,43 | ||||
2018-03-20 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 6 708 | 18 153 | 58,61 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 091 | 0 | −100,00 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −857 | 1 091 | −43,99 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −381 | 24 844 | −1,51 | 292,78 | −111 549 | 7 273 826 | |
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 857 | 25 225 | 3,52 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −843 | 2 482 | −25,35 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 635 | 3 325 | −32,96 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −727 | 24 368 | −2,90 | 284,81 | −207 057 | 6 940 250 | |
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 635 | 25 095 | 6,97 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 006 | 5 442 | −15,60 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 712 | 6 448 | −20,98 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −510 | 23 460 | −2,13 | 299,38 | −152 684 | 7 023 455 | |
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 712 | 23 970 | 7,69 | ||||
2018-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 110 | 10 110 | |||||
2018-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 4 045 | 4 045 | |||||
2017-07-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −4 974 | 22 258 | −18,27 | 290,01 | −1 442 510 | 6 455 043 |
2017-07-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −7 758 | 27 232 | −22,17 | 285,00 | −2 211 030 | 7 761 120 |
2017-03-20 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 8 606 | 11 445 | 303,13 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 | 0 | −100,00 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 197 | 1 | −99,95 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 259 | 0 | −100,00 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 375 | 4 960 | −21,70 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −728 | 1 948 | −27,20 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 216 | 2 676 | −31,24 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 103 | 6 335 | −14,83 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 477 | 1 259 | −53,98 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 034 | 34 990 | −2,87 | 274,76 | −284 102 | 9 613 852 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 197 | 36 024 | 6,49 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −593 | 33 827 | −1,72 | 274,76 | −162 933 | 9 294 307 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 259 | 34 420 | 3,80 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −447 | 33 161 | −1,33 | 287,63 | −128 571 | 9 538 098 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 375 | 33 608 | 4,27 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −335 | 32 233 | −1,03 | 284,75 | −95 391 | 9 178 347 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 728 | 32 568 | 2,29 | ||||
2017-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 8 160 | 8 160 | |||||
2016-12-02 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 2 839 | 2 839 | |||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 262 | 3 802 | −24,92 | ||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −636 | 5 064 | −11,16 | ||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −300 | 31 840 | −0,93 | 258,99 | −77 697 | 8 246 242 | |
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 636 | 32 140 | 2,02 | ||||
2016-02-24 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 7 270 | 7 270 | |||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 521 | 2 674 | −36,26 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 2 147 | −49,94 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 147 | 4 195 | −21,47 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −788 | 31 504 | −2,44 | 247,22 | −194 809 | 7 788 419 | |
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 142 | 32 292 | 7,10 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −540 | 30 150 | −1,76 | 247,22 | −133 499 | 7 453 683 | |
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 147 | 30 690 | 3,88 | ||||
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −822 | 29 543 | −2,71 | 250,77 | −206 133 | 7 408 498 | |
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 498 | 30 365 | 8,96 | ||||
2015-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 5 700 | 5 700 | |||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
J - Other | −1 041 | 5 342 | −16,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −1 627 | 6 383 | −20,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 4 289 | −33,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −767 | 27 867 | −2,68 | 392,11 | −300 748 | 10 926 929 | |
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 1 627 | 28 634 | 6,02 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 009 | 27 007 | −3,60 | 392,11 | −395 639 | 10 589 715 | |
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 142 | 28 016 | 8,28 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 0 | −100,00 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 842 | 25 874 | −6,65 | 396,88 | −731 053 | 10 268 873 | |
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 27 716 | 16,42 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 2 498 | −50,00 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −818 | 23 807 | −3,32 | 402,00 | −328 836 | 9 570 414 | |
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 498 | 24 625 | 11,29 | ||||
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 821 | 0 | −100,00 | ||||
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 803 | 22 127 | −7,53 | 347,11 | −625 839 | 7 680 503 | |
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 821 | 23 930 | 19,00 | ||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 8 010 | 8 010 | |||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 6 431 | −24,99 | ||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 010 | 20 109 | −4,78 | 323,04 | −326 270 | 6 496 011 | |
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 142 | 21 119 | 11,29 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 3 909 | −50,00 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 746 | 18 977 | −8,43 | 315,54 | −550 933 | 5 988 003 | |
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 20 723 | 23,25 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 4 996 | −33,33 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −819 | 16 814 | −4,64 | 315,54 | −258 427 | 5 305 490 | |
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 498 | 17 633 | 16,50 | ||||
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 821 | 3 821 | −50,00 | ||||
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 803 | 15 135 | −10,64 | 164,40 | −296 413 | 2 488 194 | |
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 821 | 16 938 | 29,13 | ||||
2013-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 8 573 | 8 573 | |||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 7 818 | −33,33 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 275 | 13 117 | −8,86 | 164,44 | −209 661 | 2 156 959 | |
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 14 392 | 37,29 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
J - Other | −333 | 7 494 | −4,25 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 165 | 7 827 | −21,67 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −702 | 10 483 | −6,28 | 164,44 | −115 437 | 1 723 825 | |
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 165 | 11 185 | 24,00 | ||||
2012-08-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −1 165 | 9 020 | −11,44 | 142,99 | −166 583 | 1 289 770 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −18 750 | 6 250 | −75,00 | |||
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −39 320 | 0 | −100,00 | |||
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −58 070 | 10 185 | −85,08 | 150,00 | −8 710 500 | 1 527 750 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 18 750 | 68 255 | 37,87 | 49,65 | 930 938 | 3 388 861 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 39 320 | 49 505 | 386,06 | 60,56 | 2 381 219 | 2 998 023 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −29 800 | 0 | −100,00 | |||
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −49 800 | 10 185 | −83,02 | 140,00 | −6 972 000 | 1 425 900 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 29 800 | 59 985 | 98,72 | 49,31 | 1 469 438 | 2 957 860 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 20 000 | 30 185 | 196,37 | 45,72 | 914 400 | 1 380 058 |
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −20 000 | 10 185 | −66,26 | 135,00 | −2 700 000 | 1 374 975 |
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 20 000 | 30 185 | 196,37 | 44,73 | 894 600 | 1 350 175 |
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −16 764 | 20 000 | −45,60 | |||
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −16 764 | 10 185 | −62,21 | 130,00 | −2 179 320 | 1 324 050 |
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 16 764 | 26 949 | 164,59 | 44,73 | 749 854 | 1 205 429 |
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −3 236 | 36 764 | −8,09 | |||
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −3 236 | 10 185 | −24,11 | 130,00 | −420 680 | 1 324 050 |
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 3 236 | 13 421 | 31,77 | 44,73 | 144 746 | 600 321 |
2012-02-28 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −2 117 | 10 185 | −17,21 | 115,43 | −244 365 | 1 175 655 |
2012-02-28 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −2 138 | 12 302 | −14,81 | 115,43 | −246 789 | 1 420 020 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 307 | 14 440 | −8,30 | 116,39 | −152 122 | 1 680 672 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 294 | 15 747 | −7,59 | 116,39 | −150 609 | 1 832 793 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −406 | 17 041 | −2,33 | 115,53 | −46 905 | 1 968 747 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −1 739 | 17 447 | −9,06 | 115,53 | −200 907 | 2 015 652 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 822 | 7 642 | −33,34 | ||||
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 413 | 19 186 | −6,86 | 116,70 | −164 897 | 2 239 006 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 822 | 20 599 | 22,78 | ||||
2012-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | −2 842 | 16 777 | −14,49 | 118,01 | −335 384 | 1 979 854 | |
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 911 | 11 727 | −25,01 | ||||
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 257 | 19 619 | −6,02 | 117,78 | −148 049 | 2 310 726 | |
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 911 | 20 876 | 23,05 | ||||
2012-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 9 992 | 9 992 | |||||
2011-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 15 638 | 15 638 | |||||
2010-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 486 | 34 818 | −4,09 | 55,21 | −82 042 | 1 922 302 | |
2010-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 270 | 36 304 | −3,38 | 55,21 | −70 117 | 2 004 344 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 666 | 0 | −100,00 | ||||
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −847 | 27 792 | −2,96 | 52,42 | −44 400 | 1 456 857 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 666 | 28 639 | 10,26 | ||||
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 217 | 25 973 | −4,48 | 52,61 | −64 026 | 1 366 440 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 486 | 27 190 | −5,18 | 52,61 | −78 178 | 1 430 466 | |
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 333 | 3 333 | −50,00 | ||||
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 129 | 17 716 | −5,99 | 60,00 | −67 740 | 1 062 960 | |
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 333 | 18 845 | 21,49 |